期刊文献+

胃癌GEO芯片结合TCGA数据差异基因筛选、功能及通路研究

Screening and integrative analysis of GEO chips and TCGA data for differentially expressed genes in gastric cancer
下载PDF
导出
摘要 目的筛选影响胃癌发生发展过程的相关基因及其通路,以探讨其发病机制。方法从基因表达数据库(GEO)中筛选数据集,利用GEO2R分析胃癌组织和正常组织中显著差异表达基因。使用Bio venn获得两数据集共有差异基因,将胃癌两GEO芯片共有差异表达基因数据与癌症基因组图谱(TCGA)数据库中筛选出的差异表达基因进行交集,并对其进行功能注释、KEGG富集、筛选核心互作基因,Kaplan-Meier plotter分析核心互作基因总体生存率。结果从GSE55696和GSE79973芯片中筛选出27个共有差异基因,与TCGA-STAD中有交集的差异表达基因有17个。涉及亨利恒等循环、葡萄糖的跨膜转运、胰岛素分泌的负调节和胆固醇生物合成等生物过程。主要存在于细胞外空隙、分泌颗粒内腔中,富集在金属羧肽酶活性功能方面。涉及PPAR信号通路、炎症介质对TRP通道的调节等39个通路,3个基因富集PPAR信号通路,7个基因互作关系较强,4个高表达基因生存曲线明显预后较差。结论核心基因SLC2A2、HMGCS2、APOA1、KNG1和PPAR信号通路可能是胃癌发生发展过程中的关键因素。 Objective To screen the core genes and related pathways in the pathogenesis of gastric cancer(GC)and the molecular mechanisms underlying GC pathogenesis.Methods Datasets were screened from the Gene Expression Omnibus(GEO)database.GEO2R was selected to analyze significantly differentially expressed genes(DEGs)in GC and normal tissues.Bio venn analysis revealed common DEGs in multiple datasets.Functional annotation,Kyoto Encyclopedia of Genes and Genomes enrichment,and selection of core interaction genes were performed.Kaplan-Meier plots were constructed to analyze the association of the core interaction genes with overall survival rate.Downloaded pathological data of The Cancer Genome Atlas Stomach Adenocarcinoma(TCGA-STAD)were used to screen DEGs.These genes were compared with the DEGs identified in the GEO GC microarray data.Results Twenty-seven common DEGs were screened in the GSE55696 and GSE79973 microchips.Of these,17 were also present in TCGA-STAD.These genes were involved in various biological processes,including Henry isocirculation,glucose transmembrane transport,and negative regulation of insulin secretion and cholesterol biosynthesis.The locales were mainly the extracellular void and secretory granule cavity and were functionally concentrated in metal carboxypeptidase activity.The 39 enriched pathways included the peroxisome proliferator-activated receptor(PPAR)signaling pathway and regulation of the transient receptor potential channel by inflammatory mediators.Three genes were enriched in the PPAR signaling pathway.Seven genes showed strong interactions with each other.The overall survival curves revealed an association between poor prognosis and the high expression of four genes.Conclusion SLC2A2,HMGCS2,APOA1,KNG1,and PPAR signaling pathways may be key factors associated with the development of GC.
作者 颜南 王润新 王正东 刘洪 张珉 张忠 YAN Nan;WANG Runxin;WANG Zhengdong;LIU Hong;ZHANG Min;ZHANG Zhong(Department of Rehabilitation,Shenyang Medical College,Shenyang 110034,China;School,Shenyang Medical Col­lege,Shenyang 110034,China;Department of Anatomy,Shenyang Medical College,Shenyang 110034,China;Department of Computer Science,Shenyang Medical College,Shenyang 110034,China;Department of Pathology,Shenyang Medical College,Shenyang 110034,China)
出处 《中国医科大学学报》 CAS CSCD 北大核心 2022年第4期329-335,共7页 Journal of China Medical University
基金 辽宁省教育厅科学研究项目(SYYX202007,SYYX201901)。
关键词 胃癌 生物信息学分析 基因芯片 差异表达基因 gastric cancer bioinformatics analysis gene chips differentially expressed gene
  • 相关文献

参考文献3

二级参考文献46

  • 1Clay CE, Namen AM, Atsumi G, Trimboli AJ, Fonteh AN, High KP, Chilton FH. Magnitude of peroxisome proliferator-activated receptor-gamma activation is associated with important and seemingly opposite biological responses in breast cancer cells. J Investig Med 2001; 49: 413-420.
  • 2Clay CE, Monjazeb A, Thorburn J, Chilton FH, High KP. 15-Deoxy-delta12,14-prostaglandin J2-induced apoptosis does not require PPARgamma in breast cancer cells. J Lipid Res 2002; 43: 1818-1828.
  • 3Place AE, Suh N, Williams CR, Risingsong R, Honda T, Honda Y, Gribble GW, Leesnitzer LM, Stimmel JB, Willson TM, Rosen E, Sporn MB. The novel synthetic triterpenoid, CDDO-imidazolide, inhibits inflammatory response and tumor growth in vivo. Clin Cancer Res 2003; 9: 2798-2806.
  • 4Wang M, Wise SC, Leff T, Su TZ. Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-gamma. Diabetes 1999; 48: 254-260.
  • 5Castrillo A, Mojena M, Hortelano S, Boscá L. Peroxisome proliferator-activated receptor-gamma-independent inhibition of macrophage activation by the non-thiazolidinedione agonist L-796,449. Comparison with the effects of 15-deoxy-delta(12,14)-prostaglandin J(2). J Biol Chem 2001; 276: 34082-34088.
  • 6Okano H, Shiraki K, Inoue H, Yamanaka Y, Kawakita T, Saitou Y, Yamaguchi Y, Enokimura N, Yamamoto N, Sugimoto K, Murata K, Nakano T. 15-deoxy-delta-12-14-PGJ2 regulates apoptosis induction and nuclear factor-kappaB activation via a peroxisome proliferator-activated receptor-gamma-independent mechanism in hepatocellular carcinoma. Lab Invest 2003; 83: 1529-1539.
  • 7Weber SM, Scarim AL, Corbett JA. PPARgamma is not required for the inhibitory actions of PGJ2 on cytokine signaling in pancreatic beta-cells. Am J Physiol Endocrinol Metab 2004; 286: E329-E336.
  • 8Shimada T, Kojima K, Yoshiura K, Hiraishi H, Terano A. Characteristics of the peroxisome proliferator activated receptor gamma (PPARgamma) ligand induced apoptosis in colon cancer cells. Gut 2002; 50: 658-664.
  • 9Eibl G, Wente MN, Reber HA, Hines OJ. Peroxisome proliferator-activated receptor gamma induces pancreatic cancer cell apoptosis. Biochem Biophys Res Commun 2001; 287: 522-529.
  • 10Ohta K, Endo T, Haraguchi K, Hershman JM, Onaya T. Ligands for peroxisome proliferator-activated receptor gamma inhibit growth and induce apoptosis of human papillary thyroid carcinoma cells. J Clin Endocrinol Metab 2001; 86: 2170-2177.

共引文献157

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部